ConductScience.org, home

Paper1465751

Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot study.

Gallacher SJ and 7 others. Thorax, 1992. Cited by 63 papers, by iCite.

Cite this record

ConductScience Library. Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot study. Papers, record 1465751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1465751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot study.
PubMed
Journal
Thorax
PubMed
Year
1992
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
63
iCite
Relative citation ratio, by iCite
2.98
iCite
Revised in PubMed
2019-05-03
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gallacher SJS J
2Fenner JAJ A
3Anderson KK
4Bryden FMF M
5Banham SWS W
6Logue FCF C
7Cowan RAR A
8Boyle ITI T

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AsthmaMajor topic
DiphosphonatesMajor topic
OsteoporosisMajor topic
SarcoidosisMajor topic
Adult
Aged
Bone Density
Cervical Vertebrae
Female
Femur
Fractures, Spontaneous
Humans
Infusions, Intravenous
Male
Middle Aged
Pamidronate
Pilot Projects

Source PubMed

Download CSV of topics

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12109197Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis.N Engl J Med1990https://conductscience.org/library/papers/2109197PubMed
21773137A comparison of low versus high dose pamidronate in cancer-associated hypercalcaemia.Bone Miner1991https://conductscience.org/library/papers/1773137PubMed
378209Bone disease after jejuno-ileal bypass for obesity.Lancet1978https://conductscience.org/library/papers/78209PubMed
41768163Clinical experience with pamidronate in the treatment of Paget's disease of bone.Ann Rheum Dis1991https://conductscience.org/library/papers/1768163PubMed
52865417Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.Lancet1985https://conductscience.org/library/papers/2865417PubMed
64102275Diphosphonates and Page's disease of bone.Lancet1971https://conductscience.org/library/papers/4102275PubMed
76143140Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease.Lancet1984https://conductscience.org/library/papers/6143140PubMed
86616314Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis.Calcif Tissue Int1983https://conductscience.org/library/papers/6616314PubMed
91859154A two-site immunoradiometric assay for PTH(1-84) using N and C terminal specific monoclonal antibodies.Ann Clin Biochem1991https://conductscience.org/library/papers/1859154PubMed
102407167Glucocorticoid-induced osteoporosis: pathogenesis and management.Ann Intern Med1990https://conductscience.org/library/papers/2407167PubMed
112567810Side-effects of pamidronate.Lancet1989https://conductscience.org/library/papers/2567810PubMed
122892989Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).Lancet1988https://conductscience.org/library/papers/2892989PubMed
133085989Absorption of oral diphosphonate in normal subjects.Clin Endocrinol (Oxf)1986https://conductscience.org/library/papers/3085989PubMed
144645238Routine assay of total urinary hydroxyproline based on resin-catalysed hydrolysis.Clin Chim Acta1972https://conductscience.org/library/papers/4645238PubMed
156298567Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy.Metabolism1983https://conductscience.org/library/papers/6298567PubMed
166548074Circulating vitamin D metabolites and hypercalcaemia of malignancy.Acta Endocrinol (Copenh)1984https://conductscience.org/library/papers/6548074PubMed
176720458Bone histomorphometry in corticosteroid-induced osteoporosis and Cushing's syndrome.Adv Exp Med Biol1984https://conductscience.org/library/papers/6720458PubMed
186969728Effects off short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man.J Clin Endocrinol Metab1981https://conductscience.org/library/papers/6969728PubMed
196866051Steroid-induced fractures and bone loss in patients with asthma.N Engl J Med1983https://conductscience.org/library/papers/6866051PubMed
20874087Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose.J Clin Invest1977https://conductscience.org/library/papers/874087PubMed

See all 22 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.

PMIDTitleJournalYearIn PapersSource
18415512[Not Available].Schmerz1995https://conductscience.org/library/papers/18415512PubMed
17122953Advances in the management of corticosteroid-induced osteoporosis with bisphosphonates.Clin Rheumatol2007https://conductscience.org/library/papers/17122953PubMed
10070271Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment. A double blind, randomised placebo controlled study.Ann Rheum Dis1998https://conductscience.org/library/papers/10070271PubMed
9820881Prevention and treatment of glucocorticoid-induced osteoporosis.Pharm World Sci1998https://conductscience.org/library/papers/9820881PubMed
9709383Osteoporosis in adults with cystic fibrosis.J R Soc Med1998https://conductscience.org/library/papers/9709383PubMed
9666934Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosis.Osteoporos Int1998https://conductscience.org/library/papers/9666934PubMed
9638395Pathogenesis and treatment of glucocorticoid-induced osteoporosis.Drugs Aging1998https://conductscience.org/library/papers/9638395PubMed
8941496Corticosteroid-induced bone loss. Prevention and management.Drug Saf1996https://conductscience.org/library/papers/8941496PubMed
8852571Intravenous administration of alendronate counteracts the in vivo effects of glucocorticoids on bone remodeling.Calcif Tissue Int1996https://conductscience.org/library/papers/8852571PubMed
8845585Bisphosphonates and the treatment of bone disease in the elderly.Drugs Aging1996https://conductscience.org/library/papers/8845585PubMed
8706593Comparative clinical pharmacology and therapeutic use of bisphosphonates in metabolic bone diseases.Drugs1996https://conductscience.org/library/papers/8706593PubMed
7950525The therapeutic use of bisphosphonates.BMJ1994https://conductscience.org/library/papers/7950525PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1465751

GET https://conductscience.org/api/papers/v1/1465751/references?page=2